Pancreatic progenitor cell

Jun 27, 2019

ViaCyte Appoints Sandra E. Poole to Board of Directors

May 02, 2019

Removal of Gene Completely Prevents Development of Aggressive Pancreatic Cancer in Mice

Jan 29, 2019

ViaCyte Announces New Board Members

Jan 04, 2019

ViaCyte Provides Update on Patent Portfolio in Stem Cell-Derived Cell Replacement Therapies for Type 1 Diabetes and Other Indications

Sep 27, 2018

ViaCyte to Present at Investor, Partnering, and Scientific Conferences in October

Sep 25, 2018

Gore Strengthens Collaborative Relationship with ViaCyte by Investing Additional $10 Million

Apr 12, 2018

ViaCyte to Present at Alliance for Regenerative Medicine's 6th Annual Cell & Gene Therapy Investor Day in New York City

Jan 19, 2018

ViaCyte to Present at Three Upcoming Healthcare Events

Jun 15, 2017

ViaCyte Presents at the ISSCR 2017 Annual Meeting in Boston